THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 22 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,294,000 | +112.1% | 1,318,000 | +100.0% | 0.00% | – |
| Q3 2021 | $610,000 | -3.2% | 659,000 | 0.0% | 0.00% | – |
| Q2 2021 | $630,000 | -49.9% | 659,000 | -46.4% | 0.00% | -100.0% |
| Q1 2021 | $1,257,000 | -34.2% | 1,229,000 | -39.0% | 0.00% | 0.0% |
| Q4 2020 | $1,910,000 | +40.1% | 2,016,000 | +33.0% | 0.00% | 0.0% |
| Q3 2020 | $1,363,000 | -75.6% | 1,516,000 | -73.8% | 0.00% | -75.0% |
| Q1 2020 | $5,586,000 | +62.3% | 5,788,000 | +74.0% | 0.00% | +100.0% |
| Q4 2019 | $3,442,000 | +15.5% | 3,326,000 | +3.1% | 0.00% | 0.0% |
| Q3 2019 | $2,979,000 | +27.9% | 3,226,000 | +20.1% | 0.00% | +100.0% |
| Q2 2019 | $2,330,000 | +24.7% | 2,686,000 | +39.2% | 0.00% | 0.0% |
| Q1 2019 | $1,869,000 | – | 1,930,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 13,473,000 | $12,756,000 | 1.74% |
| Shaolin Capital Management LLC | 14,065,000 | $13,281,000 | 0.93% |
| ZAZOVE ASSOCIATES LLC | 3,773,000 | $3,584,000 | 0.44% |
| FARALLON CAPITAL MANAGEMENT LLC | 56,695,000 | $53,806,000 | 0.32% |
| Baupost Group | 30,000,000 | $28,396,000 | 0.26% |
| Aequim Alternative Investments LP | 3,000,000 | $2,840,000 | 0.21% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,100,000 | $22,817,000 | 0.17% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $5,257,000 | 0.15% |
| SSI INVESTMENT MANAGEMENT LLC | 1,750,000 | $1,648,000 | 0.12% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 430,000 | $406,000 | 0.06% |